Mustang Bio

is a New York-based clinical-stage biopharmaceutical company that researches and develops cell and gene therapies for the treatment of cancer and genetic diseases...
Read more
Mustang Bio President & CEO: Manuel Litchman

President & CEO

Manuel Litchman

CEO Approval Rating

90/100

2015

PublicAcquired by Fortress BiotechNASDAQMBIO

2836 NAICS listing
Annual Revenue
$2.4M
Employees
100
Funding
$354.3M

Mustang Bio Competitors

1Abeona
2Adverum
3Astellas
4AVROBIO
5Sio Gene Therapies
6AVEO
7InterMune
8ADC Bio
9Roche
10Meditope
See 21+ competitors

Trending Companies